Journal
CANCERS
Volume 12, Issue 10, Pages -Publisher
MDPI
DOI: 10.3390/cancers12102996
Keywords
multiple myeloma; epigenetics; DNA methylation; histone acetylation; non-coding RNAs
Categories
Funding
- Associazione Italiana per la Ricerca sul Cancro (Fondazione AIRC)
- European Hematology Association
- Fondazione Regionale per la Ricerca Biomedica/ERA-NET TRANSCAN-2
- AstraZeneca
Ask authors/readers for more resources
Simple Summary Multiple Myeloma (MM) is a blood cancer characterized by an uncontrolled growth of cells named plasma cells, within the bone marrow. Patients with MM may present with anemia, bone lesions and kidney impairment. Several studies have been performed in order to provide an explanation to how this tumor may develop. Among them, the so called epigenetic modifications certainly represent important players that have been shown to support MM development and disease progression. The present article aims to summarize the current knowledge in the specific are of epigenetics in MM. Multiple myeloma (MM) is a plasma cell dyscrasia characterized by proliferation of clonal plasma cells within the bone marrow. Several advances in defining key processes responsible for MM pathogenesis and disease progression have been made; and dysregulation of epigenetics, including DNA methylation and histone modification, has emerged as a crucial regulator of MM pathogenesis. In the present review article, we will focus on the role of epigenetic modifications within the specific context of MM.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available